Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China | MSCI China Small-Cap | Hang Seng Index | Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

Sciwind

Obesity drug maker Sciwind IPO

Obesity drug maker Sciwind targets IPO, with heavyweight backers

Supported by Tencent and Meituan, the biotech aims to launch a targeted GLP-1 drug next year that could challenge established products, but it faces stiff competition Key Takeaways: • Clinical…
October 9, 2025

FAST NEWS: Biotech Startup Sciwind Lands $70 Million in New Funding

The latest: Biotech startup Hangzhou Sciwind Biosciences Co. Ltd. announced it has closed its third funding round, raising 450 million yuan ($70 million). New backers in the latest round included…
October 12, 2021

Recent Articles

Obesity drug maker Sciwind IPO
October 9, 2025

Obesity drug maker Sciwind targets IPO, with heavyweight backers

October 12, 2021

FAST NEWS: Biotech Startup Sciwind Lands $70 Million in New Funding

RELATED ARTICLES

  1. Hengrui Pharma targets obesity drug launch
    July 24, 2025
    Hengrui Pharma targets obesity drug launch after test success
    1278.HK 600276.SHG
  2. May 8, 2025
    RNA drug developer Ribo Life targets fresh funding channel
  3. June 26, 2025
    ​​Medtide launches IPO to bulk up its weight-loss business
    3880.HK
  4. May 29, 2025
    3SBio hits the big time with $6 billion cancer drug deal
    1530.HK
  5. August 28, 2025
    Precision cancer drugs show promise for Kelun-Biotech
    6990.HK
  6. May 22, 2025
    Will Trump’s drug order put the brakes on China’s overseas pharma drive?
  7. August 15, 2025
    XtalPi scores landmark deal for AI drug discovery
    2228.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.